Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Awada, G. (Speaker), Ɩzdemir, I. (Contributor), Schwarze, J. K. (Contributor), Emma Daeninck (Contributor), Gondry, O. (Contributor), Jansen, Y. (Contributor), Teofila Seremet (Contributor), Keyaerts, M. (Contributor), Everaert, H. (Contributor), Neyns, B. (Contributor)

Activiteit: Talk or presentation at a conference

Description

Poster Presentation - 21P
Periode14 dec 2018
EvenementstitelESMO Immuno-Oncology Congress 2018
EvenementstypeConference
LocatieGeneva, Switzerland
Mate van erkenningInternational